Acorda Therapeutics Inc., of Hawthorne, N.Y., added King Lee as vice president of regulatory affairs.
Akzo Nobel NV, of Arnhem, the Netherlands, appointed Paul Matson senior vice president of human resources.
Amylin Pharmaceuticals Inc., of San Diego, elected Joseph Sullivan to its board and audit committee.
Argenta Discovery Ltd., of Harlow, England, appointed Chris McGuigan to its scientific advisory board.
Attenuon LLC, of San Diego, appointed Williams Ettouati chief business officer.
Axonyx Inc., of New York, named Colin Neill chief financial officer and treasurer.
Benitec Ltd., of Queensland, Australia, named John Rossi chair of its scientific advisory board.
BioHouston, of Houston, named Peter Traber, Jacqueline Northcut Waugh, Lloyd Bentsen, Robert Gray, Steven Miller, Massey Villarreal, Steven Currall, Mark Wallace and Bernard Harris to its board. Jacqueline Northcut Waugh was also named CEO.
Callisto Pharmaceuticals Inc., of New York, named Michael Zelefsky to its board.
CytoGenix Inc., of Houston, added Cy Stein and Raymond Ocampo to its board.
Embrex Inc., of Research Triangle Park, N.C., added Jose Antonio Varona Beascoechea general manager, Mexico.
Emisphere Technologies Inc., of Tarrytown, N.Y., elected Arthur Dubroff to its board.
Enhance Biotech Inc., of New York, appointed Malcolm Thomas to its science advisory board and a member of the science team.
Forbes Medi Tech Inc., of Vancouver, British Columbia, appointed Nitin Kaushal to its board.
GlycoMimetics Inc., of Rockville, Md., appointed Franklin Top and John Baldwin to its board.
NeurogesX Inc., of San Carlos, Calif., appointed Thorsten von Stein as chief medical officer.
Northfield Laboratories Inc., of Evanston, Ill., added Eva Essig as vice president of regulatory affairs.
Scion Pharmaceuticals Inc., of Medford, Mass., added Ray Winquist as vice president of pharmacology.
Seattle Genetics Inc., of Bothell, Wash., promoted Eric Dobmeier to vice president, corporate affairs.
Telik Inc., of Palo Alto, Calif., elected May Ann Gray to its board.
Wilex AG, of Munich, Germany, named David Ebsworth chairman of its supervisory board. It also named Jeremy Reffin and Sven Warnaar members of the board.